Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bedranol 160mg tablets
0204000R0BDAHAL
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 2 |
|
Propranolol 40mg/5ml oral liquid
0204000R0AACLCL
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 2 |
|
Angilol 10mg tablets
0204000R0BZACAH
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Inderal 40mg tablets
0204000R0BGABAJ
|
Inderal | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Inderal LA 160mg capsules
0204000R0BGAGAB
|
Inderal | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Propranolol 50mg/5ml oral liquid
0204000R0AACHCH
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Propranolol 5mg/5ml oral liquid
0204000R0AACICI
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | 1 |
|
Angilol 40mg tablets
0204000R0BZABAJ
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Angilol 80mg tablets
0204000R0BZAAAK
|
Angilol (Genesis Pharmaceuticals Ltd) | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Dupromex 10mg tablets
0204000R0BWAAAH
|
Dupromex | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderal 10mg tablets
0204000R0BGAAAH
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderal 1mg/1ml solution for injection ampoules
0204000R0BGAEAC
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderal 80mg tablets
0204000R0BGACAK
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 1.67mg/5ml oral liquid
0204000R0AACMCM
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 15mg/5ml oral liquid
0204000R0AACRCR
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 16mg/5ml oral liquid
0204000R0AADEDE
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 1mg/1ml solution for injection ampoules
0204000R0AAACAC
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 2.5mg/5ml oral liquid
0204000R0AACSCS
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 2.75mg/5ml oral liquid
0204000R0AACQCQ
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 20mg/5ml oral liquid
0204000R0AACPCP
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 22.5mg/5ml oral liquid
0204000R0AADGDG
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 25mg/5ml oral liquid
0204000R0AACKCK
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 2mg/5ml oral liquid
0204000R0AACUCU
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 3.5mg/5ml oral liquid
0204000R0AACZCZ
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Propranolol 32mg/5ml oral liquid
0204000R0AADADA
|
Propranolol hydrochloride | Propranolol hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.